US EditionA Global Population-Based Study on the Association Between Ketamine and Esketamine With Suicidality Using WHO VigiBase
Summary by psychiatrist.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
A Global Population-Based Study on the Association Between Ketamine and Esketamine With Suicidality Using WHO VigiBase
A Global Population-Based Study on the Association Between Ketamine and Esketamine With Suicidality Using WHO VigiBase Ketamine and esketamine are well-established treatments for adults with treatment-resistant depression (TRD).1,2 While both agents have demonstrated antisuicidal effects, concerns about the emergence or amplification of suicidality in psychiatric populations have not been ruled out and may pose a risk for select patients.3–8 Giv…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium